Conceptio › Archive › HAL (France)
HAL (France)open access

Patient‐Perceived Benefits of Named‐Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real‐World Cohort Study

Davide Caimmi et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
questionnaires
1, PROMs, Patient's benefit, NPP, 0, Questionnaires, Sublingual allergen immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 254241
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.